( en | de | ru )

 

Disambiguation of "Sommer, Morten O."

Author of the publication

copydeleteadd this publication to your clipboard
Bacteria subsisting on antibiotics.

, , , and . Science (New York, N.Y.), 320 (5872): 100--103 (Apr 4, 2008)
DOI: 10.1126/science.1155157

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Morten Weidemann

Morten Karnuth

Morten Blöcker

Morten Trachterna

Morten Reitmayer

 

Other publications of authors with the same name

Functional characterization of the antibiotic resistance reservoir in the human microflora., , and . Science (New York, N.Y.), 325 (5944): 1128--1131 (Aug 28, 2009)Simulating Serial-Target Antibacterial Drug Synergies Using Flux Balance Analysis., , , , , , and . PloS one, (2016)Evolutionary dynamics of bacteria in a human host environment., , , , , , , , , and 3 other author(s). Proceedings of the National Academy of Sciences of the United States of America, 108 (18): 7481--7486 (May 3, 2011)Context matters - the complex interplay between resistome genotypes and resistance phenotypes., and . Current opinion in microbiology, 15 (5): 577--582 (Oct 3, 2012)Bacteria subsisting on antibiotics., , , and . Science (New York, N.Y.), 320 (5872): 100--103 (Apr 4, 2008)The shared antibiotic resistome of soil bacteria and human pathogens., , , , , and . Science (New York, N.Y.), 337 (6098): 1107--1111 (Aug 31, 2012)A functional metagenomic approach for expanding the synthetic biology toolbox for biomass conversion., , and . Molecular systems biology, (Apr 13, 2010)Functional metagenomic investigations of the human intestinal microbiota., , , and . Frontiers in microbiology, (2011)The human microbiome harbors a diverse reservoir of antibiotic resistance genes., , and . Virulence, 1 (4): 299--303 (2010)Prediction of resistance development against drug combinations by collateral responses to component drugs., , , , and . Science translational medicine, 6 (262): 262ra156 (Nov 12, 2014)